(Q37994346)

https://insomniatabletsuk.com/product/zolpidem-ambien-10-mg/

26 August 2017

title

Zolpidem for insomnia. (English)

1 reference

26 August 2017

0 references

1

David J Greenblatt

1 reference

26 August 2017

Thomas Roth

2

1 reference

PubMed ID

22424586

26 August 2017

language of work or name

English

0 references

publication date

19 March 2012

1 reference

Expert Opinion on Pharmacotherapy

26 August 2017

1 reference

26 August 2017

13

1 reference

26 August 2017

6

1 reference

26 August 2017

879-893

1 reference

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

26 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem: a review of its use in the management of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Mechanism of action of the hypnotic zolpidem in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

GABA(A) receptor subtypes: dissecting their pharmacological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

GABA A receptors: subtypes provide diversity of function and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Behavioral pharmacology of zolpidem relative to benzodiazepines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem: distinct from triazolam?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

EEG profile of intravenous zolpidem in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Population study of triazolam pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

The influence of age and sex on the clearance of cytochrome P450 3A substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

The current state of knowledge on age, sex, and their interactions on clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Aging biology and geriatric clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem pharmacokinetic properties in young females: influence of smoking and oral contraceptive use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Differential impairment of triazolam and zolpidem clearance by ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Effect of zolpidem on human cytochrome P450 activity, and on transport mediated by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Sedative effects and impaired learning and recall after single oral doses of lorazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Comparison of the daytime sleep and performance effects of zolpidem versus triazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Sedative, memory, and performance effects of hypnotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

The safety and tolerability of zolpidem--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Comparative tolerability of newer agents for insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

A postmarketing study of relative abuse liability of hypnotic sedative drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Limitations and strengths of spontaneous reports data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Epidemiology of medication-related falls and fractures in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Postural Instability and Consequent Falls and Hip Fractures Associated with Use of Hypnotics in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Residual effects of hypnotics: epidemiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Effect of hypnotic drugs on body balance and standing steadiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem use and hip fractures in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Medical conditions and medications as risk factors of falls in the inpatient older people: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Medication use and increased risk of falls in hospitalized elderly patients: a retrospective, case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

The impact of benzodiazepines on safe driving

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Benzodiazepine-like hypnotics and the associated risk of road traffic accidents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Increased risk of hospitalization related to motor vehicle accidents among people taking zolpidem: a case-crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Fatigue, sleepiness, and performance in simulated versus real driving conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Fatigue, sleep restriction, and performance in automobile drivers: a controlled study in a natural environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Sleep disorders, sleepiness and traffic safety: a public health menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Road accidents caused by drivers falling asleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

The road to danger: the comparative risks of driving while sleepy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Driver sleepiness and risk of serious injury to car occupants: population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Residual effects of sleep medication on driving ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem and traffic safety - the importance of treatment compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Sleep driving: sleepwalking variant or misuse of z-drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Hypnosedative-induced complex behaviours : incidence, mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Efficacy and safety of zolpidem extended release in elderly primary insomnia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Sublingual zolpidem tartrate lozenge for the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Insomnia causes, consequences, and therapeutics: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Prevalence, burden, and treatment of insomnia in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Correlates and consequences of chronic insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Socioeconomic impact of insomnia in working populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Insomnia and the performance of US workers: results from the America insomnia survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Effect of fluvoxamine on the pharmokinetics of zolpidem: a two-treatment period study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Rifampin reduces plasma concentrations and effects of zolpidem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Drug interaction between St John's wort and zolpidem in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

Safety and tolerance of zolpidem in the treatment of disturbed sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.667074

10.1517/14656566.2012.667074

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22424586